Katrien Princen
Head in vitro drug development
reMYND NV
BelgiumResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Katrien Princen is the Head of In Vitro Drug Development at reMYND NV, located in Belgium. Her research focuses on pharmacological modulation of septins and its implications for neuroprotection in Alzheimer's disease, with a particular emphasis on restoring calcium homeostasis. Dr. Princen's work contributes significantly to the understanding of neurodegenerative disorders and the development of therapeutic strategies.
Articles (1)
Year:
2024
Collaborators (1)
Nikolaos Louros
Assistant Professor
University of Texas Southwestern Medical Center
UNITED STATES
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.